The Therapeutic Potential of Psychedelics in the Treatment of Substance Use Disorders
Substance use disorders (SUDs) remain among the most persistent global public health challenges. Despite decades of pharmacological and behavioral innovation, relapse rates remain high, and many individuals struggle to find treatments that address both the physiological and psychological drivers of addiction. Substance use is frequently intertwined with trauma, depression, anxiety, emotional dysregulation, and diminished self-awareness, […] The post The Therapeutic Potential of Psychedelics in the Treatment of Substance Use Disorders appeared first on OPEN Foundation.
External link. We are not responsible for the content.
Read more ↗More From OPEN Foundation
Ketamine-Assisted Psychotherapy for Mental Disorders: What Does the Evidence Actually Show?
A new systematic review in Clinical Psychology Review offers the most comprehensive overview to date of studies combi...
The Perils of Non-Hallucinogenic Claims: On the Limits of Translatability
This is Part II of a double feature discussing the current stage in research and development of the different classes...
DMT and the Brain: A New Doorway Into Brain Renewal
In the past years, psychedelic science has focused heavily on how substances like psilocybin, LSD, and ayahuasca affe...
Latest News
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
AtaiBeckley is in structured discussions with pharma companies and royalty investors about a potential partnership fo...
Psilocybin Isn’t Legal Yet. So, Why Are States Writing Laws for It?
PLUS ketamine spoons, sleep tripping, and psilocybin vs. anti-depressants. [...] Read More... The post Psilocybin Isn...
A new “magic mushroom” drug could treat depression without psychedelic hallucinations
Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending s...
The Subtle Harms of Psychedelic-Assisted Therapy and Facilitation (Part 2)
Psychedelic therapy, due to the combination of heightened suggestibility, powerful altered states, and unique power i...
AtaiBeckley’s MDMA product could treat social anxiety; HHS Secretary Kennedy talks psychedelics on Rogan podcast; WV Senate and SD legislature pass Compass trigger bills
Plus: Pilot study uses psilocybin for post-treatment Lyme disease and Psychedelic-assisted therapy bill rejected then...
Pα+ February 2026 Psychedelic Bill Roundup
A state-by-state and federal review of psychedelics-related bills introduced or advanced in February 2026, including ...